Tempest Reports Third Quarter 2024 Financial Results andProvides Business Update

TPST Stock  USD 0.80  0.03  3.61%   
Slightly above 51% of Tempest Therapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Tempest Therapeutics suggests that many traders are impartial. Tempest Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Tempest Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Building upon a successful end-of-Phase 2 meeting, received FDA Study May Proceed letter for pivotal Phase 3 trial of amezalpat combination...

Read at globenewswire.com
Macroaxis News: globenewswire.com
  

Tempest Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Tempest Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tempest Therapeutics Fundamental Analysis

We analyze Tempest Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tempest Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tempest Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

Tempest Therapeutics is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Tempest Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tempest Therapeutics stock to make a market-neutral strategy. Peer analysis of Tempest Therapeutics could also be used in its relative valuation, which is a method of valuing Tempest Therapeutics by comparing valuation metrics with similar companies.

Peers

Tempest Therapeutics Related Equities

ARMPArmata Pharmaceuticals   4.29   
0%
33.0%
AKTXAkari Therapeutics   2.11   
0%
16.0%
ANEBAnebulo Pharmaceuticals   0.72   
0%
5.0%
FBRXForte Biosciences   0.52   
0%
4.0%
OLMAOlema Pharmaceuticals   0.45   
0%
3.0%
RVMDRevolution Medicines   0.18   
0%
1.0%
IKNAIkena Oncology   0.60   
4.0%
0%
INDPIndaptus Therapeutics   0.99   
7.0%
0%
RZLTRezolute   1.08   
8.0%
0%
ZNTLZentalis Pharmaceuticals   1.28   
9.0%
0%
GLUEMonte Rosa   2.95   
23.0%
0%
RNXTRenovoRx   3.03   
23.0%
0%
CGEMCullinan Oncology   3.69   
28.0%
0%
PCSAProcessa Pharmaceuticals   11.20   
87.0%
0%
LYELLyell Immunopharma   11.84   
92.0%
0%
SANASana Biotechnology   12.82   
100.0%
0%

Additional Tools for Tempest Stock Analysis

When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.